Zobrazeno 1 - 10
of 406
pro vyhledávání: '"Dowless M"'
Autor:
VandeKopple, M., Mur, C., Shen, W., Marugan, C., Capen, A., Huber, L., Castanares, M.A., Garcia-Tapia, D., Mattioni, B., Bastian, J., Manro, J., Pulliam, N., Dowless, M., Ruiz, M.J. Ortiz, Lallena, M.J., De Dios, A., Gong, X.
Publikováno v:
In ESMO Open May 2023 8(1) Supplement 4
Autor:
Schubert, N.A., Chen, C.Y., Rodríguez, A., Koster, J., Dowless, M., Pfister, S.M., Shields, D.J., Stancato, L.F., Vassal, G., Caron, H.N., van den Boogaard, M.L., Henssen, A.G., Molenaar, J.J.
BACKGROUND: Childhood cancer is still a leading cause of death around the world. To improve outcomes, there is an urgent need for tailored treatment. The systematic evaluation of existing preclinical data can provide an overview of what is known and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=mdc______med::6853450f7c1f9ec570f24939d9437cea
http://edoc.mdc-berlin.de/21697/1/21697oa.pdf
http://edoc.mdc-berlin.de/21697/1/21697oa.pdf
Autor:
Schubert NA; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Chen CY; Department of Pediatric Hematology and Oncology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Rodríguez A; Hoffman-La Roche, Basel, Switzerland., Koster J; Department of Oncogenomics, Amsterdam University Medical Center, Amsterdam, the Netherlands., Dowless M; Eli Lilly and Company, Indianapolis, IN, USA., Pfister SM; Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK) and University Hospital, Heidelberg, Germany., Shields DJ; Pfizer Centers for Therapeutic Innovation, Pfizer Inc., New York, NY, USA., Stancato LF; Eli Lilly and Company, Indianapolis, IN, USA., Vassal G; Institute Gustave Roussy, Université Paris Saclay, Villejuif, France., Caron HN; Hoffman-La Roche, Basel, Switzerland., van den Boogaard ML; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Henssen AG; Department of Pediatric Hematology and Oncology, Charité-Universitätsmedizin Berlin, Berlin, Germany; Berlin Institute of Health, Berlin, Germany; German Cancer Consortium (DKTK), Partner Site Berlin, And German Cancer Research Center (DKFZ), Heidelberg, Germany; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany., Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pharmaceutical Sciences, University Utrecht, Utrecht, Netherlands. Electronic address: j.j.molenaar@prinsesmaximacentrum.nl.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Jul; Vol. 170, pp. 196-208. Date of Electronic Publication: 2022 Jun 04.
Autor:
Huang, Zhu1,2 (AUTHOR) huangzhu@xmu.edu.cn, Li, Wenjing2 (AUTHOR), Wu, Yan2 (AUTHOR), Cheng, Bing1 (AUTHOR), Huang, Shile3,4 (AUTHOR) shile.huang@lsuhs.edu
Publikováno v:
Cells (2073-4409). Nov2024, Vol. 13 Issue 21, p1752. 19p.
Autor:
Tate, Cm, Pallini, Roberto, Ricci Vitiani, L, Dowless, M, Shiyanova, T, D'Alessandris, Gq, Morgante, Liliana, Giannetti, Stefano, Larocca, Luigi Maria, Di Martino, S., Rowlinson, Sw, De Maria, R, Stancato, L., De Maria Marchiano, Ruggero
Glioblastoma multiforme (GBM) is among the most aggressive tumor types and is essentially an incurable malignancy characterized by resistance to chemo-, radio-, and immunotherapy. GBM is maintained by a hierarchical cell organization that includes st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70f34904c98a92163ae737a5942b8e4b
http://hdl.handle.net/10807/111728
http://hdl.handle.net/10807/111728
Autor:
Awada, Ahmad1 (AUTHOR) ahmadawada21@gmail.com, Ahmad, Sarfraz1 (AUTHOR) ahmadawada21@gmail.com
Publikováno v:
Current Oncology. Sep2024, Vol. 31 Issue 9, p5374-5383. 10p.
Autor:
Cristalli, Camilla1 (AUTHOR) camilla.cristalli@ior.it, Scotlandi, Katia1 (AUTHOR) camilla.cristalli@ior.it
Publikováno v:
Cells (2073-4409). Jul2024, Vol. 13 Issue 14, p1209. 37p.
Autor:
Lowery CD; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Blosser W; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Dowless M; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Renschler M; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Perez LV; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Stephens J; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Pytowski B; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Wasserstrom H; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Stancato LF; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Falcon B; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA.
Publikováno v:
Oncotarget [Oncotarget] 2019 Sep 17; Vol. 10 (53), pp. 5523-5533. Date of Electronic Publication: 2019 Sep 17 (Print Publication: 2019).
Autor:
Lowery CD; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana., Dowless M; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana., Renschler M; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana., Blosser W; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana., VanWye AB; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana., Stephens JR; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana., Iversen PW; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana., Lin AB; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana., Beckmann RP; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana., Krytska K; The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania., Cole KA; The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania., Maris JM; The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania., Hawkins DS; Division of Hematology/Oncology, Seattle Children's Hospital, Seattle, Washington., Rubin BP; Departments of Pathology and Cancer Biology, Robert J Tomsich Pathology and Laboratory Medicine Institute and Cleveland Clinic, Cleveland, Ohio., Kurmasheva RT; Greehey Children's Cancer Research Institute, San Antonio, Texas., Houghton PJ; Greehey Children's Cancer Research Institute, San Antonio, Texas., Gorlick R; MD Anderson Cancer Center, Houston, Texas., Kolb EA; Nemours Center for Cancer and Blood Disorders, Wilmington, Delaware., Kang MH; Texas Tech University Health Sciences Center, Lubbock, Texas., Reynolds CP; Texas Tech University Health Sciences Center, Lubbock, Texas., Erickson SW; RTI International, Research Triangle Park, North Carolina., Teicher BA; National Cancer Institute, Bethesda, Maryland., Smith MA; National Cancer Institute, Bethesda, Maryland., Stancato LF; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana. stancato_louis@lilly.com.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2019 Apr 01; Vol. 25 (7), pp. 2278-2289. Date of Electronic Publication: 2018 Dec 18.
Autor:
Gong X; Eli Lilly and Company, Indianapolis, Indiana., Du J; Eli Lilly and Company, Indianapolis, Indiana., Parsons SH; Eli Lilly and Company, Indianapolis, Indiana., Merzoug FF; Eli Lilly and Company, Indianapolis, Indiana., Webster Y; Eli Lilly and Company, Indianapolis, Indiana., Iversen PW; Eli Lilly and Company, Indianapolis, Indiana., Chio LC; Eli Lilly and Company, Indianapolis, Indiana., Van Horn RD; Eli Lilly and Company, Indianapolis, Indiana., Lin X; Eli Lilly and Company, Indianapolis, Indiana., Blosser W; Eli Lilly and Company, Indianapolis, Indiana., Han B; Eli Lilly and Company, Indianapolis, Indiana., Jin S; Eli Lilly and Company, Indianapolis, Indiana., Yao S; Eli Lilly and Company, Indianapolis, Indiana., Bian H; Eli Lilly and Company, Indianapolis, Indiana., Ficklin C; Eli Lilly and Company, Indianapolis, Indiana., Fan L; Eli Lilly and Company, Indianapolis, Indiana., Kapoor A; Eli Lilly and Company, Indianapolis, Indiana., Antonysamy S; Eli Lilly and Company, Discovery Chemistry Research and Technologies, Lilly Biotechnology Center, San Diego, California., Mc Nulty AM; Eli Lilly and Company, Indianapolis, Indiana., Froning K; Eli Lilly and Company, Discovery Chemistry Research and Technologies, Lilly Biotechnology Center, San Diego, California., Manglicmot D; Eli Lilly and Company, Discovery Chemistry Research and Technologies, Lilly Biotechnology Center, San Diego, California., Pustilnik A; Eli Lilly and Company, Discovery Chemistry Research and Technologies, Lilly Biotechnology Center, San Diego, California., Weichert K; Eli Lilly and Company, Discovery Chemistry Research and Technologies, Lilly Biotechnology Center, San Diego, California., Wasserman SR; Eli Lilly and Company, Advanced Photon Source, Argonne National Laboratory, Argonne, Illinois., Dowless M; Eli Lilly and Company, Indianapolis, Indiana., Marugán C; Eli Lilly and Company, Lilly Research Laboratories, Avenida de la Industria, Alcobendas, Spain., Baquero C; Eli Lilly and Company, Lilly Research Laboratories, Avenida de la Industria, Alcobendas, Spain., Lallena MJ; Eli Lilly and Company, Lilly Research Laboratories, Avenida de la Industria, Alcobendas, Spain., Eastman SW; Eli Lilly and Company, Alexandria Center for Life Sciences, New York, New York., Hui YH; Eli Lilly and Company, Indianapolis, Indiana., Dieter MZ; Eli Lilly and Company, Indianapolis, Indiana., Doman T; Eli Lilly and Company, Indianapolis, Indiana., Chu S; Eli Lilly and Company, Indianapolis, Indiana., Qian HR; Eli Lilly and Company, Indianapolis, Indiana., Ye XS; Eli Lilly and Company, Indianapolis, Indiana., Barda DA; Eli Lilly and Company, Indianapolis, Indiana., Plowman GD; Eli Lilly and Company, Indianapolis, Indiana., Reinhard C; Eli Lilly and Company, Indianapolis, Indiana., Campbell RM; Eli Lilly and Company, Indianapolis, Indiana., Henry JR; Eli Lilly and Company, Indianapolis, Indiana., Buchanan SG; Eli Lilly and Company, Indianapolis, Indiana. buchananse@lilly.com.
Publikováno v:
Cancer discovery [Cancer Discov] 2019 Feb; Vol. 9 (2), pp. 248-263. Date of Electronic Publication: 2018 Oct 29.